{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T16:16:15Z","timestamp":1699719375109},"reference-count":23,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1979,6,1]]},"DOI":"10.1136\/adc.54.6.454","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T21:33:49Z","timestamp":1229981629000},"page":"454-458","source":"Crossref","is-referenced-by-count":16,"title":["Carbamazepine dose-frequency requirement in children."],"prefix":"10.1136","volume":"54","author":[{"given":"G W","family":"Rylance","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T A","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2125.1978.tb01604.x","article-title":"A method for obtaining saliva samples from infants and children","volume":"5","author":"Bacon, C.G.; Mucklow, J.C.; Saunders, A.; Rawlins, M.D.; Webb, J.K.G.","year":"1978","unstructured":"Bacon, C. G., Mucklow, J. C., Saunders, A., Rawlins, M. D., and Webb, J. K. G. (1978). A method for obtaining saliva samples from infants and children. British Journal of Clinical Pharmacology, 5, 89-90.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00443121","article-title":"Use of saliva in monitoring carbamazepine medication in epileptic children","volume":"126","author":"Bartels, H.; Oldigs, H.-D.; Gunther, E.","year":"1977","unstructured":"Bartels, H., Oldigs, H-D., and Gunther, E. (1977). Use of saliva in monitoring carbamazepine medication in epileptic children. European Journal of Pediatrics, 126, 37-44.","journal-title":"European Journal of Pediatrics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3476(72)80561-4","article-title":"Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationship in children","volume":"81","author":"Borofsky, L.G.; Louis, S.; Kutt, H.; Roginsky, M.","year":"1972","unstructured":"Borofsky, L. G., Louis, S., Kutt, H., and Roginsky, M. (1972). Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationship in children. Journal of Pediatrics, 81, 995-1002.","journal-title":"Journal of Pediatrics"},{"key":"ref_4","first-page":"417","article-title":"Ethosuximide. Absorption, distribution, and excretion","volume-title":"Antiepileptic Drugs","author":"Chang, T.; Dill, W.A.; Glazko, A.J.","year":"1972","unstructured":"Chang, T., Dill, W. A., and Glazko, A. J. (1972). Ethosuximide. Absorption, distribution, and excretion. In Antiepileptic Drugs, pp. 417-423. Edited by D. M. Woodbury, J. K. Penry, and R. P. Schmidt. Raven Press: New York."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00562659","article-title":"Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses","volume":"8","author":"Eichelbaum, M.; Ekbom, K.; Bertilsson, L.; Ringberger, V.A.; Rane, A.","year":"1975","unstructured":"Eichelbaum, M., Ekbom, K., Bertilsson, L., Ringberger, V. A., and Rane, A. (1975). Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. European Journal of Clinical Pharmacology, 8, 337-341.","journal-title":"European Journal of Clinical Pharmacology"},{"key":"ref_6","first-page":"127","article-title":"The biotransformation","volume-title":"of carbamazepine (Tegretol). In Epileptic Seizures-BehaviourPain","author":"Faigle, J.W.; Brechbuhler, S.; Feldmann, K.F.; Richter, W.J.","year":"1976","unstructured":"Faigle, J. W., Brechbuhler, S., Feldmann, K. F., and Richter, W. J. (1976). The biotransformation of carbamazepine (Tegretol). In Epileptic Seizures-BehaviourPain, pp. 127-140. Edited by W. Birkmayer. Hans Huber: Berne."},{"key":"ref_7","first-page":"2","article-title":"Sleep epilepsy: its pattern and progress","author":"Gibberd, F.B.; Bateson, M.C.","year":"1974","unstructured":"Gibberd, F. B., and Bateson, M. C. (1974). Sleep epilepsy: its pattern and progress. British MedicalJournal, 2,403-405.","journal-title":"British MedicalJournal"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.1976.tb04878.x","article-title":"CSF concentrations and serum protein binding of carbamazepine and carbamazepine 10, 11-epoxide in epileptic patients","volume":"3","author":"Johannessen, S.I.; Gerna, M.; Bakke, J.; Strandjord, R.E.; Morselli, P.L.","year":"1976","unstructured":"Johannessen, S. I., Gerna, M., Bakke, J., Strandjord, R. E., and Morselli, P. L. (1976). CSF concentrations and serum protein binding of carbamazepine and carbamazepine 10, 11-epoxide in epileptic patients. British Journal of Clinical Pharmacology, 3, 575-582.","journal-title":"British Journal of Clinical Pharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.1968.03140110061012","article-title":"Management of epilepsy with diphenylhydantoin sodium","volume":"203","author":"Kutt, H.; McDowell, F.","year":"1968","unstructured":"Kutt, H., and McDowell, F. (1968). Management of epilepsy with diphenylhydantoin sodium. Journal of the American Medical Association, 203, 969-972.","journal-title":"Journal of the American Medical Association"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archneur.1974.00490410031001","article-title":"Usefulness of blood levels of antiepileptic drugs","volume":"31","author":"Kutt, H.; Penry, J.K.","year":"1974","unstructured":"Kutt, H., and Penry, J. K. (1974). Usefulness of blood levels of antiepileptic drugs. Archives of Neurology, 31, 283-288.","journal-title":"Archives of Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/clinchem\/21.11.1658","article-title":"Therapeutic monitoring of anticonvulsant drugs: gas chromatographic simultaneous determination ofprimidone phenylethylmalonamide, carbamazepine, and diphenylhydantoin","volume":"21","author":"Least, Jr, C.J.; Johnson, G.F.; Solomon, H.M.","year":"1975","unstructured":"Least, C. J., Jr, Johnson, G. F., and Solomon, H. M. (1975). Therapeutic monitoring of anticonvulsant drugs: gas chromatographic simultaneous determination ofprimidone phenylethylmalonamide, carbamazepine, and diphenylhydantoin. Clinical Chemistry, 21, 1658-1662.","journal-title":"Clinical Chemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.27.5.409","article-title":"Salivary levels of anticonvulsants: a practical approach to drug monitoring","volume":"27","author":"McAuliffe, J.J.; Sherwin, A.L.; Leppik, I.E.; Fayle, S.A.; Pippenger, C.E.","year":"1977","unstructured":"McAuliffe, J. J., Sherwin, A. L., Leppik, I. E., Fayle, S. A., and Pippenger, C. E. (1977). Salivary levels of anticonvulsants: a practical approach to drug monitoring. Neurology, 27, 409-413.","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1212\/WNL.26.10.936","article-title":"Further observations on carbamazepine plasma levels in epileptic patients","volume":"26","author":"Monaco, F.; Riccio, A.; Benna, P.; Covacich, A.; Durelli, L.; Fantini, M.; Furlan, P.M.; Gilli, M.; Mutani, R.; Troni, W.; Gerna, M.; Morselli, P.L.","year":"1976","unstructured":"Monaco, F., Riccio, A., Benna, P., Covacich, A., Durelli, L., Fantini, M., Furlan, P. M., Gilli, M., Mutani, R., Troni, W., Gerna, M., and Morselli, P. L. (1976). Further observations on carbamazepine plasma levels in epileptic patients. Neurology, 26, 936-943.","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03602537508993750","article-title":"Metabolism and pharmacokinetics of carbamazepine","volume":"4","author":"Morselli, P.L.; Frigerio, A.","year":"1975","unstructured":"Morselli, P. L., and Frigerio, A. (1975). Metabolism and pharmacokinetics of carbamazepine. Drug Metabolism Reviews, 4, 97-113.","journal-title":"Drug Metabolism Reviews"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1528-1157.1975.tb04762.x","article-title":"Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients","volume":"16","author":"Morselli, P.L.; Monaco, F.; Gerna, M.; Ricchia, M.; Rutio, A.","year":"1975","unstructured":"Morselli, P. L., Monaco, F., Gerna, M., Ricchia, M., and Rutio, A. (1975). Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. Epilepsia, 16, 759-764.","journal-title":"Epilepsia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cpt1976193276","article-title":"Kinetics of carbamazepine and its 10, 11-epoxide metabolite in children","volume":"19","author":"Rane, A.; Hojer, B.; Wilson, J.T.","year":"1976","unstructured":"Rane, A., Hojer, B., and Wilson, J. T. (1976). Kinetics of carbamazepine and its 10, 11-epoxide metabolite in children. Clinical Pharmacology and Therapeutics, 19, 276-283.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"ref_17","first-page":"384","article-title":"Salivary phenytoin concentrations in epilepsy and in chronic renal failure","volume":"2","author":"Reynolds, F.; Ziroyanis, P.N.; Jones, N.F.; Smith, S.E.","year":"1976","unstructured":"Reynolds, F., Ziroyanis, P. N., Jones, N. F., and Smith, S. E. (1976). Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet, 2, 384-386.","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1136\/bmj.2.6100.1481","article-title":"Letter: Saliva carbamazepine levels in children","volume":"2","author":"Rylance, G.W.; Butcher, G.M.; Moreland, T.A.","year":"1977","unstructured":"Rylance, G. W., Butcher, G. M., and Moreland, T. A. (1977). Letter: Saliva carbamazepine levels in children. British Medical Journal, 2, 1481.","journal-title":"British Medical Journal"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1528-1157.1975.tb04758.x","article-title":"Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid","volume":"16","author":"Schmidt, D.; Kupferberg, H.J.","year":"1975","unstructured":"Schmidt, D., and Kupferberg, H. J. (1975). Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia, 16, 735-741.","journal-title":"Epilepsia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archpedi.1964.02090010084011","article-title":"Diphenylhydantoin and phenobarbital serum levels in children","volume":"108","author":"Svensmark, O.; Buchthal, F.","year":"1964","unstructured":"Svensmark, O., and Buchthal, F. (1964). Diphenylhydantoin and phenobarbital serum levels in children. American Journal of Diseases of Children, 108, 82-87.","journal-title":"American Journal of Diseases of Children"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1528-1157.1975.tb06051.x","article-title":"Anticonvulsant level in saliva, serum, and cerebrospinal fluid","volume":"16","author":"Troupin, A.S.; Friel, P.","year":"1975","unstructured":"Troupin, A. S., and Friel, P. (1975). Anticonvulsant level in saliva, serum, and cerebrospinal fluid. Epilepsia, 16, 223-227.","journal-title":"Epilepsia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0404.1975.tb01383.x","article-title":"Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin)","volume":"60","author":"Troupin, A.S.; Green, J.R.; Halpern, L.M.","year":"1975","unstructured":"Troupin, A. S., Green, J. R., and Halpern, L. M. (1975). Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin). Acta neurologica Scandinavica, 60, Supplement, 13-26.","journal-title":"Acta neurologica Scandinavica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cpt1978233320","article-title":"Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva","volume":"23","author":"Westenberg, H.G.M.; van der Kleijn, E.; Oei, T.T.; de Zeeuw, R.A.","year":"1978","unstructured":"Westenberg, H. G. M., van der Kleijn, E., Oei, T. T., and de Zeeuw, R. A. (1978). Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva. Clinical Pharmacology and Therapeutics, 23, 320-328.","journal-title":"Clinical Pharmacology and Therapeutics"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.54.6.454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T09:13:22Z","timestamp":1601111602000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.54.6.454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,6,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1979,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.54.6.454","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,6,1]]}}}